These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Feasibility of changing therapeutic cyclosporine monitoring from C(0) to C(2) in stable renal recipients: narrower coefficient of variation with C(2) monitoring. Chueh SC; Liao CH; Chang CJ; Lai MK Transplant Proc; 2001; 33(7-8):3100-1. PubMed ID: 11750332 [No Abstract] [Full Text] [Related]
8. Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients. Braun F; Armstrong VW; Lorf T; Canelo R; Arndt C; Oellerich M; Ringe B Transplant Proc; 2001; 33(7-8):3108-9. PubMed ID: 11750336 [No Abstract] [Full Text] [Related]
9. C0/C2 cyclosporine levels monitoring in renal transplantation. Santana A; Guerra J; Milhomens C; Neves F; Prata MM Transplant Proc; 2003 May; 35(3):1072-3. PubMed ID: 12947862 [No Abstract] [Full Text] [Related]
10. Neoral (cyclosporine) C2 monitoring in renal transplant recipients: a single-center experience in Asia. Wong HS; Morad Z Transplant Proc; 2003 Feb; 35(1):230-1. PubMed ID: 12591376 [No Abstract] [Full Text] [Related]
11. Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral. Keshavamurthy M; Al Ahmadi I; Mohammed Raza S; Baynton R; Al Meshari K; Al Shaibani K Transplant Proc; 2001; 33(7-8):3112-4. PubMed ID: 11750338 [No Abstract] [Full Text] [Related]
13. High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome. Cicciarelli J; Avila D; Iwaki Y; Sather H; Mendez R Transplant Proc; 1998 Aug; 30(5):1683-4. PubMed ID: 9723243 [No Abstract] [Full Text] [Related]
14. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience. Wilczek HE; Akesson P; Warholm C Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267 [No Abstract] [Full Text] [Related]
15. A retrospective analysis of Neoral C2 monitoring in Chinese renal transplantation recipients. Tan J; Tang X Transplant Proc; 2003 Feb; 35(1):232-3. PubMed ID: 12591377 [No Abstract] [Full Text] [Related]
16. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study. Park K; Kim MS; Kim SI; Kim YS; Moon JI Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557 [No Abstract] [Full Text] [Related]
17. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation. Yu L; Wang Y; Fu SJ; Cheng XJ Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902 [No Abstract] [Full Text] [Related]
18. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients. Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379 [No Abstract] [Full Text] [Related]
19. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant. Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892 [No Abstract] [Full Text] [Related]
20. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring. Sharma A; Shekhar C; Heer M; Minz M Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]